Characteristics of Epstein-Barr virus-associated gastric cancer: A study of 235 cases at a comprehensive cancer center in U.S.A

Journal of Experimental and Clinical Cancer Research

Volumn 28, Issue 1, 2009, Pages

  Truong, Camtu D ^a   Feng, Wei ^b   Li, Wei ^b   Khoury, T ^c   Li, Q ^c   Alrawi, S ^d   Yu, Yingyan ^e   Xie, Keping ^a   Yao, James ^a   Tan, Dongfeng ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

^e TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE; PARAFFIN; EBV ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN BARR VIRUS; EBV-ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN-BARR VIRUS; MATRIX PROTEIN; VIRUS RNA;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER CELL; CANCER CENTER; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CELLULAR DISTRIBUTION; EPSTEIN BARR VIRUS; FEMALE; GENDER; GOLD STANDARD; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; INTESTINE METAPLASIA; LIFESTYLE; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STAINING; STOMACH CARCINOMA; STOMACH MUCOSA; STROMA CELL; TUMOR CELL; UNITED STATES; VIRUS DETECTION; VIRUS INFECTION; VIRUS REPLICATION; ADENOCARCINOMA; BIOSYNTHESIS; GENETICS; IMMUNOHISTOCHEMISTRY; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; STOMACH TUMOR; VIROLOGY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GASTRIC MUCOSA; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; RNA, VIRAL; STOMACH NEOPLASMS; TUMOR VIRUS INFECTIONS; UNITED STATES; VIRAL MATRIX PROTEINS; YOUNG ADULT;

EID: 60849132738     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-28-14     Document Type: Article

References (34)

1. Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. AP Burke TSB Yen KM Shekitka, Mod Pathol 1990 3 377 380 2163534
2. Association of Epstein-Barr virus with undifferentiated gastric carcinoma with intense lymphoid infiltration. D Shibata M Tokunaga Y Uemura, Am J Pathol 1991 139 469 474 1653517
3. Epstein-Barr virus-associated gastric adenocarcinoma. D Shibata LM Weiss, Am J Pathol 1992 140 769 774 1314023
4. Epstein-Barr virus in gastric carcinomas and gastric stump carcinomas: a late event in gastric carcinogenesis. A Zur Hausen BP van Rees J van Beek, J Clin Pathol 2004 57 487 491 15113855 10.1136/jcp.2003.014068
5. Epstein-Barr virus and gastric carcinoma. K Takada, Mol Pathol 2000 53 255 261 11091849 10.1136/mp.53.5.255
6. Epstein-Barr virus-associated carcinomas: facts and fiction. K Herrmann G Niedobitek, J Pathol 2003 199 140 145 10.1002/path.1296 12533825
7. Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric adenocarcinomas: expression of the transforming BARF1 gene. A zur Hausen AA Brink ME Craanen, Cancer Res 2000 60 2745 2748 10825150
8. Distinct chromosomal aberrations in Epstein-Barr virus-carrying gastric carcinomas tested by comparative genomic hybridization. A zur Hausen NC van Grieken GA Meijer, Gastroenterology 2001 121 612 618 10.1053/gast.2001.27200 11522745
9. Epstein-Barr Virus and Gastric Carcinoma - Viral Carcinogenesis through Epigenetic Mechanisms. H Uozaki M Fukayama, Int J Clin Exp Pathol 2008 1 3 198 216 18784828
10. Monoclonal Epstein-Barr virus genomes but lack of EBV-related protein expression in different types of gastric carcinoma. G Ott T Kirchner HK Muller-Hermelink, Histopathology 1994 25 323 329 10.1111/j.1365-2559.1994. tb01350.x 7835837
11. Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. S Imai S Koizumi M Sugiura, Proc Natl Acad Sci USA 1994 91 9131 9135 8090780 10.1073/pnas.91.19.9131
12. Epstein-Barr virus and gastric remnant cancer. N Yamamoto M Tokunaga Y Uemura, Cancer 1994 74 805 809 10.1002/1097-0142(19940801)74:3<805::AID- CNCR2820740304>3.0.CO;2-L 8039108
13. Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation. ML Gulley DR Pulitzer PA Eagan, Hum Pathol 1996 27 20 27 10.1016/S0046-8177(96)90133-1 8543306
14. Epstein-Barr virus infection in non-carcinomatous gastric epithelium. H Yanai K Takada N Shimizu, J Pathol 1997 183 293 298 10.1002/(SICI)1096- 9896(199711)183:3<293::AID-PATH937>3.0.CO;2-C 9422984
15. Epstein-Barr virus-associated gastric carcinoma and atrophic gastritis. H Yanai T Murakami H Yoshiyama, J Clin Gastroenterol 1999 29 39 43 10.1097/00004836-199907000-00010 10405229
16. Pathogenic roles for Epstein-Barr virus (EBV) gene products in EBV-associated proliferative disorders. JM Middeldorp AA Brink AJ van den Brule, Crit Rev Oncol Hematol 2003 45 1 36 10.1016/S1040-8428(02)00078-1 12482570
17. World Health Organisation, Classification of tumours. Pathology and genetics, tumours of the digestive system Lyon: IARC 2000
18. Altered E-cadherin and epidermal growth factor receptor expressions are associated with patient survival in lung cancer: a study utilizing high-density tissue microarray and immunohistochemistry. G Deeb J Wang N Ramnath HK Slocum S Wiseman A Beck D Tan, Mod Pathol 2004 17 4 430 9 10.1038/modpathol.3800041 14739904
19. Association of Epstein-Barr virus with gastric carcinoma with lymphoid stroma. K Oda J Tamaru T Takenouchi A Mikata M Nunomura H Saito, Am J Pathol 1993 143 1063 8214002
20. HER-2/neu protein expression and gene alteration in stage I-IIIA non-small-cell lung cancer: a study of 140 cases using a combination of high throughput tissue microarray, immunohistochemistry, and fluorescent in situ hybridization. D Tan G Deeb J Wang HK Slocum J Winston S Wiseman A Beck S Sait T Anderson C Nwogu N Ramnath G Loewen, Diagn Mol Pathol 2003 12 4 201 11 10.1097/00019606-200312000-00004 14639106
21. Thyroid Transcription Factor-1(TTF-1) Expression Prevalence and Its Clinical Implications in Non-Small-Cell Lung Cancer: A High-Throughput Tissue Microarray and Immunohistochemistry Study. D Tan Li Qiang Deeb George N Ramnath H Slocum R Cheney T Anderson J Brooks S Wiseman G Loewen, Human Pathol 2003 34/6 597 604 10.1016/S0046-8177(03)00180-1
22. Upregulation of the tissue inhibitor of metalloproteinase-1 protein is associated with progression of human non-small-cell lung cancer. IS Aljada N Ramnath K Donohue S Harvey JJ Brooks SM Wiseman T Khoury G Loewen HK Slocum TM Anderson G Bepler D Tan, J Clin Oncol 2004 22 16 3218 29 10.1200/JCO.2004.02.110 15249585
23. Nonparametric estimation from incomplete observation. EL Kaplan P Meier, J Am Stat Assoc 1958 53 457 481 10.2307/2281868
24. Categorical Data Analysis. A Agresti, New York, NY, John Wiley & Sons 1990 306 347
25. Evidence of lytic infection of Epstein-Barr virus (EBV) in EBV-positive gastric carcinoma. Y Hoshikawa Y Satoh M Murakami M Maeta N Kaibara H Ito T Kurata T Sairenji, J Med Virol 2002 66 351 359 10.1002/jmv.2152 11793387
26. The comparison of the prognosis between Epstein-Barr virus (EBV)-positive gastric carcinomas and EBV-negative ones. Y Kijima S Ishigami S Hokita Coriyama S Akiba Y Eizuru T Aikou, Cancer Letters 2003 33 40 10.1016/S0304-3835(03) 00410-5 14550950
27. Detection of Epstein-Barr virus in gastric carcinoma cells and surrounding lymphocytes. Kenji Oda 1 Keiji Koda 1 Nobuhiro Takiguchi 2 Masao Nunomura 3 Kazuhiro Seike 1 Masaru Miyazaki, Gastric Cancer 2003 6 3 173 178 10.1007/s10120-003-0247-2 14520531
28. EBV-positive gastric adenocarcinomas: a distinct clinicopathological entity with a low frequency of lymph node involvement. J van Beek A zur Hausen E Klein Kranenbarg, J Clin Oncol 2004 22 664 670 10.1200/JCO.2004.08.061 14966089
29. Microsatellite instability and Epstein-Barr virus infection in gastric remnant cancers. MS Chang JH Lee JP Kim HS Kim HS Lee CW Kim YI Kim WH Kim, Pathol Int 2000 50 6 486 92 10.1046/j.1440-1827.2000.01072.x 10886725
30. Expression of Epstein-Barr virus genes in EBV-associated gastric carcinomas. Bing Luo Yun Wang Xiao-Feng Wang Hua Liang Li-Ping Yan Bao-Hua Huang Peng Zhao, World J Gastroenterol 2005 11 5 629 633 15655811
31. Evidence of lytic infection of Epstein-Barr virus (EBV) in EBV-positive gastric carcinoma. Y Hoshikawa Y Satoh M Murakami, J Med Virol 2002 66 351 359 10.1002/jmv.2152 11793387
32. Epstein-Barr virus-associated gastric carcinoma: Evidence of age-dependence among a Mexican population. R Herrera-Goepfert S Akiba C Koriyama S Ding E Reyes T Itoh Y Minakami Y Eizuru, World J Gastroenterol 2005 11 39 6096 103 16273633
33. Epstein-Barr virus in gastric carcinoma. M Tokunaga CE Land Y Uemura, Am J Pathol 1254 143 1250 1993
34. Epstein-Barr virus involvement is mainly restricted to lymphoepithelial type of gastric carcinoma among various epithelial neoplasms. Y Kijima S Hokita S Takao, J Med Virol 2001 64 513 518 10.1002/jmv.1079 11468737